Your browser doesn't support javascript.
loading
The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group.
Papageorgiou, Sotirios G; Kontos, Christos K; Kotsianidis, Ioannis; Vasilatou, Diamantina; Symeonidis, Argyris; Galanopoulos, Athanasios; Bouchla, Anthi; Hatzimichael, Eleftheria; Repousis, Panagiotis; Zikos, Panagiotis; Viniou, Nora-Athina; Poulakidas, Elias; Vassilakopoulos, Theodoros P; Diamantopoulos, Panagiotis; Diamantopoulos, Marios A; Mparmparousi, Despoina; Bouronikou, Eleni; Papadaki, Helen; Panayiotidis, Panayiotis; Pappa, Vasiliki.
Afiliación
  • Papageorgiou SG; Second Department of Internal Medicine and Research Unit, University General Hospital "Attikon", Athens, Greece.
  • Kontos CK; Department of Biochemistry and Molecular Biology, University of Athens, Athens, Greece.
  • Kotsianidis I; Department of Hematology, Democritus University of Thrace Medical School, University Hospital of Alexandroupolis, Alexandroupolis, Greece.
  • Vasilatou D; The Hellenic (Greek) MDS Study Group, Athens, Greece.
  • Symeonidis A; Second Department of Internal Medicine and Research Unit, University General Hospital "Attikon", Athens, Greece.
  • Galanopoulos A; The Hellenic (Greek) MDS Study Group, Athens, Greece.
  • Bouchla A; General University Hospital of Patras, Patras, Greece.
  • Hatzimichael E; The Hellenic (Greek) MDS Study Group, Athens, Greece.
  • Repousis P; General Hospital of Athens 'G. Gennimatas', Athens, Greece.
  • Zikos P; Second Department of Internal Medicine and Research Unit, University General Hospital "Attikon", Athens, Greece.
  • Viniou NA; University Hospital of Ioannina, Ioannina, Greece.
  • Poulakidas E; Department of Hematology, 'Metaxa' Piraeus Cancer Hospital, Piraeus, Greece.
  • Vassilakopoulos TP; General Hospital of Patras 'Agios Andreas', Patras, Greece.
  • Diamantopoulos P; The Hellenic (Greek) MDS Study Group, Athens, Greece.
  • Diamantopoulos MA; First Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Mparmparousi D; '401' Army General Hospital of Athens, Athens, Greece.
  • Bouronikou E; Department of Haematology, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.
  • Papadaki H; First Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Panayiotidis P; Department of Biochemistry and Molecular Biology, University of Athens, Athens, Greece.
  • Pappa V; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
Hematol Oncol ; 36(4): 693-700, 2018 Oct.
Article en En | MEDLINE | ID: mdl-30129144
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Azacitidina / Síndromes Mielodisplásicos / Antimetabolitos Antineoplásicos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Hematol Oncol Año: 2018 Tipo del documento: Article País de afiliación: Grecia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Azacitidina / Síndromes Mielodisplásicos / Antimetabolitos Antineoplásicos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Hematol Oncol Año: 2018 Tipo del documento: Article País de afiliación: Grecia Pais de publicación: Reino Unido